Tower Research Capital (TRC)’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Tower Research Capital (TRC)’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-265	Closed	-$11K	–	5522
2015 Q2	$11K	Sell	265 -236	-47%	-$8.46K	﹤0.01%	2664
2015 Q1	$18K	Buy	501 +469	+1,466%	+$15.9K	﹤0.01%	2359
2014 Q4	$1K	Sell	32 -1,050	-97%	-$30.4K	﹤0.01%	3883
2014 Q3	$30K	Buy	+1,082	New	+$33K	﹤0.01%	1987
2014 Q2	–	Sell	-557	Closed	-$15K	–	5203
2014 Q1	$15K	Buy	557 +349	+168%	+$9.13K	﹤0.01%	2227
2013 Q4	$5K	Sell	208 -2,626	-93%	-$80.9K	﹤0.01%	3598
2013 Q3	$84K	Buy	2,834 +1,835	+184%	+$51K	0.01%	1454
2013 Q2	$29K	Buy	+999	New	+$27.5K	﹤0.01%	1386

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Tower Research Capital (TRC)'s BRLI Position: Q3 2015 in Review

Tower Research Capital (TRC) sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 265 shares — an estimated $11K sold.

Tower Research Capital (TRC) first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $84K in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Tower Research Capital (TRC) reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 265 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $11K.
Tower Research Capital (TRC) first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Tower Research Capital (TRC)'s BIO-REFERENCE LABS INC-NEW- position peaked at $84K in Q3 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.